Correlation Between Coca Cola and LAVA Medtech

Can any of the company-specific risk be diversified away by investing in both Coca Cola and LAVA Medtech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Coca Cola and LAVA Medtech into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between The Coca Cola and LAVA Medtech Acquisition, you can compare the effects of market volatilities on Coca Cola and LAVA Medtech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Coca Cola with a short position of LAVA Medtech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Coca Cola and LAVA Medtech.

Diversification Opportunities for Coca Cola and LAVA Medtech

-0.88

Correlation Coefficient

Coca Cola  LAVA Medtech

Pay attention - limited upside

The 3 months correlation between Coca and LAVA is -0.88. Overlapping area represents the amount of risk that can be diversified away by holding The Coca Cola and LAVA Medtech Acquisition in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on LAVA Medtech Acquisition and Coca Cola is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on The Coca Cola are associated (or correlated) with LAVA Medtech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of LAVA Medtech Acquisition has no effect on the direction of Coca Cola i.e., Coca Cola and LAVA Medtech go up and down completely randomly.

Pair Corralation between Coca Cola and LAVA Medtech

Allowing for the 90-day total investment horizon The Coca Cola is expected to generate 7.12 times more return on investment than LAVA Medtech. However, Coca Cola is 7.12 times more volatile than LAVA Medtech Acquisition. It trades about 0.02 of its potential returns per unit of risk. LAVA Medtech Acquisition is currently generating about 0.11 per unit of risk. If you would invest  5,802  in The Coca Cola on October 7, 2024 and sell it today you would earn a total of  373.00  from holding The Coca Cola or generate 6.43% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Significant
Accuracy	16.73%
Values	Daily Returns

The Coca Cola  vs.  LAVA Medtech Acquisition

Coca Cola

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days The Coca Cola has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest inconsistent performance, the Stock's basic indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.

LAVA Medtech Acquisition

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days LAVA Medtech Acquisition has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, LAVA Medtech is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.

Pair Trading with Coca Cola and LAVA Medtech

The main advantage of trading using opposite Coca Cola and LAVA Medtech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Coca Cola position performs unexpectedly, LAVA Medtech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in LAVA Medtech will offset losses from the drop in LAVA Medtech's long position.

The idea behind The Coca Cola and LAVA Medtech Acquisition pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.